E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation

Journal of Neuroscience

Volumn 34, Issue 4, 2014, Pages 1481-1493

  Magri, Laura ^a   Swiss, Victoria A ^a,d   Jablonska, Beata ^b   Lei, Liang ^c   Pedre, Xiomara ^a,e   Walsh, Martin ^a   Zhang, Weijia ^a   Gallo, Vittorio ^b   Canoll, Peter ^c   Casaccia, Patrizia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c Department of Medicine   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^e RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Brain; Cell cycle; Chromatin; Development; Tumor

Indexed keywords

BRAIN; CELL CYCLE; CHROMATIN; DEVELOPMENT; TUMOR;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; E2F1 TRANSCRIPTION FACTOR; FEMALE; GENES, CDC; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEUROGENESIS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 84892770645     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2840-13.2014     Document Type: Article

References (96)

1. AlonsoMM, Fueyo J, Shay JW, Aldape KD, Jiang H, Lee OH, Johnson DG, Xu J, Kondo Y, Kanzawa T, Kyo S, Bekele BN, Zhou X, Nigro J, McDonald JM, Yung WK, Gomez-Manzano C (2005) Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst 97:1589-1600. CrossRef Medline
2. Arifin MT, Hama S, Kajiwara Y, Sugiyama K, Saito T, Matsuura S, Yamasaki F, Arita K, Kurisu K (2006) Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas. J Neurooncol 77:273-277. CrossRef
3. Arita K, Ariyoshi M, Tochio H, Nakamura Y, ShirakawaM (2008) Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a baseflipping mechanism. Nature 455:818-821. CrossRef Medline
4. Avvakumov GV, Walker JR, Xue S, Li Y, Duan S, Bronner C, Arrowsmith CH, Dhe-Paganon S (2008) Structural basis for recognition of hemimethylatedDNAby the SRA domain of human UHRF1. Nature 455:822-825. CrossRef Medline
5. Bagchi S, Weinmann R, Raychaudhuri P (1991) The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65:1063-1072. CrossRef Medline
6. Bandara LR, Buck VM, Zamanian M, Johnston LH, La Thangue NB (1993) Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J 12:4317-4324. Medline
7. Barkess G, Postnikov Y, Campos CD, Mishra S, Mohan G, Verma S, Bustin M, West KL (2012) The chromatin-binding proteinHMGN3stimulates histone acetylation and transcription across the Glyt1 gene. Biochem J 442: 495-505. CrossRef Medline
8. Barres BA, Lazar MA, Raff MC (1994) A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120:1097-1108. Medline
9. Birger Y, Catez F, Furusawa T, Lim JH, Prymakowska-Bosak M, West KL, Postnikov YV, Haines DC, Bustin M (2005) Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1. Cancer Res 65:6711-6718. CrossRef Medline
10. Blais A, Dynlacht BD (2007) E2F-associated chromatin modifiers and cell cycle control. Curr Opin Cell Biol 19:658-662. CrossRef Medline
11. Bostick M, Kim JK, Estève PO, Clark A, Pradhan S, Jacobsen SE (2007) UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317:1760-1764. CrossRef Medline
12. Brock MV, Herman JG, Baylin SB (2007) Cancer as a manifestation of aberrant chromatin structure. Cancer J 13:3-8. Medline
13. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28:264-278. CrossRef Medline
14. Casaccia-Bonnefil P, LiuA (2003) Relationship between cell cycle molecules and onset of oligodendrocyte differentiation. J Neurosci Res 72:1-11. CrossRef Medline
15. Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich V Jr, Chao MV, Koff A (1997) Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev 11: 2335-2346. CrossRef Medline
16. Casaccia-Bonnefil P, Hardy RJ, Teng KK, Levine JM, Koff A, Chao MV (1999) Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development 126:4027-4037. Medline
17. Cole MD, McMahon SB (1999) The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18:2916-2924. CrossRef Medline
18. De Gregori J, Kowalik T, Nevins JR (1995) Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1/Sregulatory genes. Mol Cell Biol 15:4215-4224. Medline
19. DennisGJr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, LempickiRA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3. CrossRef Medline
20. Dimova DK, Dyson NJ (2005) The E2F transcriptional network: old acquaintances with new faces. Oncogene 24:2810-2826. CrossRef Medline
21. Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA (2006) Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 26:10967-10983. CrossRef Medline
22. Durand B, Gao FB, Raff M (1997) Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 16:306-317. CrossRef Medline
23. Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262. CrossRef Medline
24. Emery B (2010) Regulation of oligodendrocyte differentiation and myelination. Science 330:779-782. CrossRef Medline
25. Evans PM, Liu C (2008) Roles of Krupel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin 40:554-564. CrossRef Medline
26. Ferret-Sena V, Sena A, Besnard F, Fressinaud C, Rebel G, Sarliève LL (1990) Comparison of the mechanisms of action of insulin and triiodothyronine on the synthesis of cerebroside sulfotransferase in cultures of cells dissociated from brains of embryonic mice. Dev Neurosci 12:89-105. CrossRef Medline
27. Frederick TJ, Wood TL (2004) IGF-I and FGF-2 coordinately enhance cyclin D1 and cyclin E-cdk2 association and activity to promoteG1 progression in oligodendrocyte progenitor cells. Mol Cell Neurosci 25:480-492. CrossRef Medline
28. Frolov MV, Dyson NJ (2004) Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 117:2173-2181. CrossRef Medline
29. Gao FB, Apperly J, RaffM (1998) Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells. Dev Biol 197:54-66. CrossRef Medline
30. + channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells. J Neurosci 19:5380-5392. Medline
31. Gobert RP, Joubert L, Curchod ML, Salvat C, Foucault I, Jorand-Lebrun C, Lamarine M, Peixoto H, Vignaud C, Frémaux C, Jomotte T, Françon B, Alliod C, Bernasconi L, Abderrahim H, Perrin D, Bombrun A, Zanoguera F, Rommel C, Hooft van Huijsduijnen R (2009) Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits. Mol Cell Biol 29:1538-1553. CrossRef Medline
32. Graham V, Khudyakov J, Ellis P, Pevny L (2003) SOX2 functions to maintain neural progenitor identity. Neuron 39:749-765. CrossRef Medline
33. Hashimoto H, Vertino PM, Cheng X (2010) Molecular coupling of DNA methylation and histone methylation. Epigenomics 2:657-669. CrossRef Medline
34. He Y, Sandoval J, Casaccia-Bonnefil P (2007) Events at the transition between cell cycle exit and oligodendrocyte progenitor differentiation: the role of HDAC and YY1. Neuron Glia Biol 3:221-231. Medline
35. Helin K, Harlow E, Fattaey A (1993) Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Molecular and cellular biology 13:6501-6508. Medline
36. Hidaka T, Hama S, Shrestha P, Saito T, Kajiwara Y, Yamasaki F, Sugiyama K, Kurisu K (2009) The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma. Anticancer Res 29:597-603. Medline
37. Hilton DA, Penney M, Pobereskin L, Sanders H, Love S (2004) Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival. Histopathology 44:555-560. CrossRef Medline
38. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57. Medline
39. Huang Z, Tang XM, Cambi F (2002) Down-regulation of the retinoblastoma protein (rb) is associated with rat oligodendrocyte differentiation. Mol Cell Neurosci 19:250-262. CrossRef Medline
40. Ivanova IA, Vespa A, Dagnino L (2007) A novel mechanism of E2F1 regulation via nucleocytoplasmic shuttling: determinants of nuclear import and export. Cell Cycle 6:2186-2195. CrossRef Medline
41. Jung M, Krämer E, Grzenkowski M, Tang K, Blakemore W, Aguzzi A, Khazaie K, Chlichlia K, von Blankenfeld G, Kettenmann H, Trotter J (1995) Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur J Neurosci 7:1245-1265. CrossRef Medline
42. Kaka GR, Tiraihi T, Delshad A, Arabkheradmand J, Kazemi H (2012) In vitro differentiation of bone marrow stromal cells into oligodendrocytelike cells using triiodothyronine as inducer. Int J Neurosci 122:237-247. CrossRef Medline
43. Kato H, van Ingen H, Zhou BR, Feng H, Bustin M, Kay LE, Bai Y (2011) Architecture of the high mobility group nucleosomal protein 2-nucleosome complex as revealed by methyl-based NMR. Proc Natl Acad Sci U S A 108:12283-12288. CrossRef Medline
44. Kirla RM, Haapasalo HK, Kalimo H, Salminen EK (2003) Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas. Cancer 97:644-648. CrossRef Medline
45. Körner U, Bustin M, Scheer U, Hock R (2003) Developmental role of HMGN proteins in Xenopus laevis. Mech Dev 120:1177-1192. CrossRef Medline
46. Kugler JE, Deng T, Bustin M (2012) The HMGN family of chromatinbinding proteins: dynamic modulators of epigenetic processes. Biochim Biophys Acta 1819:652-656. CrossRef Medline
47. Kugler JE, Horsch M, Huang D, Furusawa T, Rochman M, Garrett L, Becker L, Bohla A, Hölter SM, Prehn C, Rathkolb B, Racz I, Aguilar-Pimentel JA, Adler T, Adamski J, Beckers J, Busch DH, Eickelberg O, Klopstock T, Ollert M, et al. (2013) High mobility group N proteins modulate the fidelity of the cellular transcriptional profile in a tissue-and variantspecific manner. J Biol Chem 288:16690-16703. CrossRef Medline
48. Kumar S, Kahn MA, Dinh L, de Vellis J (1998) NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo. J Neurosci Res 54:754-765. CrossRef Medline
49. Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma'ayan A (2010) ChEA: transcription factor regulation inferred from integrating genomewide ChIP-X experiments. Bioinformatics 26:2438-2444. CrossRef Medline
50. Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memoryefficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. CrossRef Medline
51. Lau P, Verrier JD, Nielsen JA, Johnson KR, Notterpek L, Hudson LD (2008) Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes. J Neurosci 28:11720-11730. CrossRef Medline
52. Lei L, Sonabend AM, Guarnieri P, Soderquist C, Ludwig T, Rosenfeld S, Bruce JN, Canoll P (2011) Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PloS One 6:e20041. CrossRef Medline
53. Liu J, Sandoval J, Doh ST, Cai L, López-Rodas G, Casaccia P (2010) Epigenetic modifiers are necessary but not sufficient for reprogramming nonmyelinating cells into myelin gene-expressing cells. PloS One 5:e13023. CrossRef Medline
54. Liu X, Gao Q, Li P, Zhao Q, Zhang J, Li J, Koseki H, Wong J (2013) UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9. Nat Commun 4:1563. CrossRef Medline
55. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109. CrossRef Medline
56. Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P (2002) Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 22:10333-10345. Medline
57. Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T (2000) Regulation of E2F1 activity by acetylation. The EMBO J 19:662-671. CrossRef
58. Marzio G, Wagener C, Gutierrez MI, Cartwright P, Helin K, GiaccaM (2000) E2F family members are differentially regulated by reversible acetylation. J Biol Chem 275:10887-10892. CrossRef Medline
59. Masaoka A, Gassman NR, Kedar PS, Prasad R, Hou EW, Horton JK, Bustin M, Wilson SH (2012) HMGN1 protein regulates poly(ADP-ribose) polymerase-1 (PARP-1) self-PARylation in mouse fibroblasts. J Biol Chem 287:27648-27658. CrossRef Medline
60. Müller H, Helin K (2000) The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta 1470:M1-M12. Medline
61. Nair SS, Kumar R (2012) Chromatin remodeling in cancer: a gateway to regulate gene transcription. Mol Oncol 6:611-619. CrossRef Medline
62. Nevins JR (1998) Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differentiation 9:585-593. Medline
63. Nishiyama A, Komitova M, Suzuki R, Zhu X (2009) Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 10: 9-22. CrossRef Medline
64. Nygård M, Wahlström GM, Gustafsson MV, Tokumoto YM, Bondesson M (2003) Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors. Mol Endocrinol 17:79-92. CrossRef Medline
65. Pasquini JM, AdamoAM (1994) Thyroid hormones and the central nervous system. Dev Neurosci 16:1-8. CrossRef Medline
66. Raff, M. (2007) Intracellular developmental timers. Cold Spring Harbor Symp Quant Biol 72 431-435.
67. Raff MC, Durand B, Gao FB (1998) Cell number control and timing in animal development: the oligodendrocyte cell lineage. Int J Dev Biol 42: 263-267. Medline
68. Reeves R (2010) Nuclear functions of the HMG proteins. Biochim Biophys Acta 1799:3-14. CrossRef Medline
69. Ruas M, PetersG (1998) The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378:F115-F177. Medline
70. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374-378. Medline
71. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311-322. CrossRef Medline
72. Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, Shinga J, Mizutani-Koseki Y, Toyoda T, Okamura K, Tajima S, Mitsuya K, Okano M, Koseki H (2007) The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450:908-912. Medline
73. Shen S, Liu A, Li J, Wolubah C, Casaccia-Bonnefil P (2008) Epigenetic memory loss in aging oligodendrocytes in the corpus callosum. Neurobiol Aging 29:452-463. CrossRef Medline
74. Sherr CJ (1994) The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends Cell Biol 4:15-18. CrossRef Medline
75. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512. CrossRef Medline
76. Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3. Medline
77. Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, Lytle J, Nait-Oumesmar B, Kerninon C, Kanai-Azuma M, Kanai Y, Gallo V (2006) Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci 26:9722-9735. CrossRef Medline
78. Sonabend AM, Yun J, Lei L, Leung R, Soderquist C, Crisman C, Gill BJ, Carminucci A, Sisti J, Castelli M, Sims PA, Bruce JN, Canoll P (2013) Murine cell line model of proneural glioma for evaluation of anti-tumor therapies. J Neuro-oncol 112:375-382. CrossRef
79. Swiss VA, Casaccia P (2010) Cell-context specific role of the E2F/Rb pathway in development and disease. Glia 58:377-390. Medline
80. Swiss VA, Nguyen T, Dugas J, Ibrahim A, Barres B, Androulakis IP, Casaccia P (2011) Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation. PloS One 6:e18088. CrossRef Medline
81. Takahashi Y, Rayman JB, DynlachtBD (2000) Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14:804-816. Medline
82. Tamiya T, Mizumatsu S, Ono Y, Abe T, Matsumoto K, Furuta T, Ohmoto T (2001) High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas. Acta Neuropathol 101:334-340. Medline
83. Tang XM, Beesley JS, Grinspan JB, Seth P, Kamholz J, Cambi F (1999) Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendrocyte differentiation. J Cell Biochem 76:270-279. Medline
84. Tikoo R, Osterhout DJ, Casaccia-Bonnefil P, Seth P, Koff A, ChaoMV (1998) Ectopic expression of p27Kip1 in oligodendrocyte progenitor cells results in cell-cycle growth arrest. J Neurobiol 36:431-440. CrossRef Medline
85. Tokumoto YM, Durand B, Raff MC (1999) An analysis of the early events when oligodendrocyte precursor cells are triggered to differentiate by thyroid hormone, retinoic acid, or PDGF withdrawal. Dev Biol 213:327-339. CrossRef Medline
86. Tokumoto YM, Apperly JA, Gao FB, Raff MC (2002) Posttranscriptional regulation of p18 and p27 Cdk inhibitor proteins and the timing of oligodendrocyte differentiation. Dev Biol 245:224-234. CrossRef Medline
87. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98-110. CrossRef Medline
88. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307-310. CrossRef Medline
89. Watanabe Y, Maekawa M (2010) Methylation of DNA in cancer. Adv Clin Chem 52:145-167. CrossRef Medline
90. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323-330. CrossRef Medline
91. Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ (2000) Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 20:5797-5807. CrossRef Medline
92. Wu M, Hernandez M, Shen S, Sabo JK, Kelkar D, Wang J, O'Leary R, Phillips GR, Cate HS, Casaccia P (2012) Differential modulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation. J Neurosci 32:6651-6664. CrossRef Medline
93. Xu X, Bieda M, Jin VX, Rabinovich A, Oberley MJ, Green R, Farnham PJ (2007) A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res 17:1550-1561. CrossRef Medline
94. Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, Dowdy SF, Chao MV, Koff A (2001) p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep 2:27-34. CrossRef Medline
95. Zhang J, Gao Q, Li P, Liu X, Jia Y, Wu W, Li J, Dong S, Koseki H, Wong J (2011) S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance. Cell Res 21: 1723-1739. CrossRef Medline
96. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9:R137. CrossRef Medline